Better Health at your fingertips

TARGETING MITOCHONDRIA

Mitochondria are pertinent targets for efficient drugs, cosmetics or functional food for better health and safer products. Find out how our tests can help advance your projects in demonstrating mechanisms of action and getting pre-clinical proof of principle.

Learn more about it
BLOOD MARKERS FOR DEMENTIA

ICDD is set to identify blood makers specifically for presymptomatic stages of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington’s disease using cellulomics in innovative patient-derived cell models & blood protein profiling.

Learn more about it
PARTNER WITH US         

You have a drug that target CNS diseases and cancers. We have companion diagnostic tests and platforms to identify subset of patients that respond to and tolerate your drug. Let’s work together to advance patient health and disease clinical management.

Learn more about it
The Science of Possibility

HARNESSING THE POWER OF SYSTEM BIOLOGY

Understanding complex processes and their dynamics is how ICDD progresses toward the identification of new candidate biomarkers associated with disease progression and/or drug response.

EVENTS WE’LL ATTEND

ICDD will be present at In‑Cosmetics Paris 2016!
Come meet Nathalie Compagnone and our team at the stand R90 to learn all about our technologies. Register before April 11th for free show entry (save 50$)!

What we do

  • Disease modeling through mitochondrial dysfunction

  • Comprehensive assessment of cell metabolism in a multiplexed fashion

  • Assessment of mitochondrial liabilities

  • Identify whether ROS production is damageable in your system

  • Performances of mtDNA control

  • Selecting disease-modifying drugs for CNS

  • Profiling clinical tolerance at the pre-clinical stage

  • Personalized medicine diagnostic co-development

  • Molecular determinants of drug response & tolerance

  • They support us